Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency
Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency
Recruiting · NCT06095141 · Registry updated 2025-08-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency | pancreatic adenocarcinoma | Recruiting | Phase 2 / Phase 3 | 2025-08-07 | NCT06095141 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai Cancer Center | Shanghai | China | 5 |